Press Releases from MEDraysintell (8 total)
Proton Therapy Industry, a first consolidation in a niche market
With the recent announcement of Hitachi to acquire the particle therapy business of Mitsubishi, we observe the first consolidation in the PT industry. Following this recent announcement, the top three vendors share now 70% of the PT market in 2017 valued at US$ 0.9 billion. Several companies are expected to enter the market for the first time in the coming years with their own PT systems. The global PT market…
MEDraysintell downgrades its proton therapy market projection
In light of several factors summarized below, MEDraysintell is downgrading its proton therapy market projection from 1,200 proton therapy treatment rooms that were expected to be operational in 2030 to 900. This still represents a 12% annual growth from 2017 to 2030 and the need to open an average of more than 50 PT treatment rooms every year from 2018 to 2030.
Originally MEDraysintell expected 2015 to become the starting point…
Future and Economics of Nuclear Medicine
Need to understand future and economics of Nuclear Medicine? Looking for experts in this field? Trying to appreciate the potential of this new technology?
MEDraysintell will display its series of market reports and directories with over 2,100 pages of unrivaled intelligence covering Nuclear Medicine, Cyclotrons, Brachytherapy and Proton Therapy, during the EANM – European Association of Nuclear Medicine – congress (Vienna, Austria, October 21-25, 2017). MEDraysintell is gratefully hosted by the…
Impulse from radiotherapeutics confirms accelerated growth of nuclear medicine
MEDraysintell releases its new Nuclear Medicine World Market Report and Directory–Edition 2017, a 1,100-page document that provides an exhaustive description and analysis of more than 390 products, including over 140 radiopharmaceuticals under clinical development, with a comprehensive profile of 193 companies and institutions active in the radiopharmaceuticals industry.
Detailed table of contents and sample pages available upon request a peg@medraysintell.com
MEDraysintell estimates that the global market for nuclear medicine reached US$ 4.5…
MEDraysintell to showcase its reports at SNNMI in Denver
MEDraysintell will display its series of market reports and directories with over 1,900 pages of unrivaled intelligence covering Nuclear Medicine, Cyclotrons, Brachytherapy and Proton Therapy, during the SNMMI – Society of Nuclear Medicine and Molecular Imaging– congress (Denver, CO, USA, June 10-14, 2017), www.snmmi.org/am2017
MEDraysintell is gratefully hosted by the company ANMI and visitors are welcome at booth #957.
MEDraysintell estimates the global market for nuclear medicine (radiopharmaceuticals) has reached US$ 4.5…
Nuclear Medicine, Proton Therapy, Brachytherapy reports and directories
Nuclear medicine, proton therapy and brachytherapy are niche markets which together represents less than 0.1% of the global health expenditures but should grow three times faster. While the global expenses on health reached some US$ 7,500 billion in 2016 and should growth by 3-4% a year to 2030, the nuclear medicine, proton therapy and brachytherapy markets reached over US$ 6 billion in 2016 and are expected to growth more than…
MEDraysintell releases its Proton Therapy Market Essentials report 2017
MEDraysintell publishes its new “Proton Therapy Market Essentials” report providing key facts and figures on Proton Therapy to advice non-industry insiders on the potential for investments, market development, merger and acquisitions (M&A) existing in this healthcare technology.
This “Proton Therapy Market Essentials” report will be a real asset for institutions looking to implement a new proton therapy center and for the financial community (investors, investment bankers and M&A professionals) to support…
MEDraysintell releases its first Nuclear Medicine Market Essentials report
MEDraysintell publishes its new “Nuclear Medicine Market Essentials” report providing key facts and figures on Nuclear Medicine to advice non-industry insiders on the potential for investments, merger and acquisitions (M&A), technology and market development existing in this healthcare technology.
This “Nuclear Medicine Market Essentials” report will be a real asset for the healthcare industry or for the financial community (investors, investment bankers and M&A professionals) to support their audit and to…
